InvestorsHub Logo
Followers 4
Posts 207
Boards Moderated 0
Alias Born 03/06/2022

Re: boi568 post# 450594

Friday, 02/02/2024 8:06:53 PM

Friday, February 02, 2024 8:06:53 PM

Post# of 459928
Note also, boi, from the recent presentation that blarcamesine also compares favorably on ADAS-Cog (on a shorter period of time) with Lilly's donanemab, the latest and supposedly greatest(?) mAb for AD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News